ADeditome

ADeditome maps A-to-I RNA editing events in Alzheimer's disease to annotate their genomic locations and potential functional impacts.


Key Features:

  • Extensive Database: catalogs 1,676,363 A-to-I RNA editing sites detected across 1,524 samples from nine brain regions using data from ROSMAP, MayoRNAseq, and MSBB.
  • Functional Annotations: provides annotations linking edits to AD stages and to effects on gene expression, protein recoding, alternative splicing, and miRNA regulation, with emphasis on Alzheimer's-related genes.
  • Pathological Insights: identifies 108,010 editing events predicted to promote AD progression, 26,168 events predicted to inhibit progression, and 5,582 brain-region-specific events with dual roles.
  • Multi-layer Data Integration: integrates multiple layers of genomic data to support comprehensive functional annotation of RNA edits.
  • Systematic Detection: applies advanced bioinformatics techniques for systematic detection and annotation of A-to-I editing events.

Scientific Applications:

  • Pathology Exploration: enables investigation of molecular mechanisms underlying AD by linking specific RNA edits to gene function and brain-region specificity.
  • Precision Medicine: supports identification of individualized therapeutic targets by associating particular RNA edits with disease progression and region-specific effects.
  • Drug Research: facilitates discovery of therapeutic strategies aimed at modulating A-to-I RNA editing processes relevant to AD.

Methodology:

Employs advanced bioinformatics techniques to systematically detect and annotate A-to-I RNA editing events and integrates multiple layers of genomic data for comprehensive functional annotation.

Topics

Details

Tool Type:
web application
Added:
3/19/2021
Last Updated:
11/24/2024

Operations

Data Inputs & Outputs

Publications

Wu S, Yang M, Kim P, Zhou X. ADeditome provides the genomic landscape of A-to-I RNA editing in Alzheimer’s disease. Briefings in Bioinformatics. 2021;22(5). doi:10.1093/bib/bbaa384. PMID:33401309. PMCID:PMC8424397.

PMID: 33401309
PMCID: PMC8424397
Funding: - National Institutes of Health: R01CA241930, R01GM123037, U01AR069395-01A1